Seth, R., Yang, S., Choi, S., Sabean, M
Semaglutide is a glucagon-like peptide 1 (GLP-1) medication whose shortage has been in effect since 2022
A study of patients with T2MD and congestive heart failure found that their levels of ANP were increased, whereas blood pressure was decreased, indicating that the GLP-1R-ANP axis is only active in patients with congestive heart failure (123)
If using oral contraceptives, remember that you need additional barrier contraception or a non-oral method for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase
Sustainable weight loss is a journey built on long-term healthy habits, not a quick fix
The Semaglutide Solution: Recent 2026 studies show that semaglutide helps maintain a higher level of satiety even as weight drops, preventing the massive spike in hunger hormones that usually causes people to quit intermittent fasting